Research Article

Interleukin-18 Expression Increases in the Aorta and Plasma of Patients with Acute Aortic Dissection

Table 3

Summary of clinical characteristics in patients who provided blood sample.

CharacteristicNADAADStanford AStanford B

Gender (M/F)19/1270/1837/833/10
Age (years)64 (50, 76)56 (50, 64)55 (46, 61)61 (53, 69)
Smoking (, %)6 (19.3)36 (40.9)18 (40)18 (41.8)
HBP (, %)25 (80.6)79 (89.7)41 (91.1)38 (88.3)
Glu (mmol/l)6.13 (5.6, 6.8)7.2 (6.4, 8.3)7.3 (6.4, 8.2)6.8 (6.3, 8.7)
SBP (mmHg)156 (146, 170)145 (128, 167)144 (121, 161) 145 (132, 170)
DBP (mmHg)84 (76, 93)80 (70, 94)75 (66, 92)80 (74, 97)
WBC (×109/L)7.5 (4.8, 11.6)11.0 (8.1, 13.5)11.6 (9.5, 14.1)10.0 (6.7, 12.9)
TC (mmol/l)4.0 (3.5, 4.3)4.07 (3.4, 4.7)4.13 (3.6, 4.7)4.0 (3.4, 4.6)
TG (mmol/l)1.4 (1.2, 1.6)1.2 (0.9, 1.7)1.2 (0.9, 1.9)1.1 (0.9, 1.7)
HDL-C (mmol/l)1.0 (0.9, 1.1)1.1 (0.9, 1.4)1.0 (0.8, 1.3)1.3 (0.9, 1.5)
LDL-C (mmol/l)2.1 (1.9, 2.3)2.2 (1.7, 2.7)2.3 (1.8, 2.8)2.0 (1.6, 2.6)
HR (bmp)72 (63, 84)78 (68, 90)78 (60, 84)80 (72, 91)
CREA (μmol/l)72 (62, 92)82 (68, 106)80 (67, 94)85 (75, 113)
D-dimer (μg/ml)0.8 (0.6, 1.0)4.2 (2.0, 6.3)4.7 (2.4, 7.2)4.0 (1.6, 5.5)
CRP (mg/l)18.4 (3.8, 60.9)10.7 (2.7, 57.4)11.8 (2.6, 61.3)9.1 (2.8, 58.8)
Medications, (%)
 Aspirin5 (16.1)13 (14.7)5 (11.1)8 (18.6)
 ACEI/ARB9 (29.0)35 (39.7)14 (31.1)21 (48.8)
 Beta-blockers4 (12.9)18 (20.4)7 (15.5)11 (25.5)
 CCB9 (29.0)33 (37.5)18 (40.0)15 (34.8)
 Diuretics3 (9.6)15 (17.0)6 (13.3)9 (20.9)

ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker. vs. NAD group.